Most Highmark subscribers will soon lose low-cost access to UPMC in a consent agreement Highmark agreed to.
Testimony continued Friday in the trial of Dr. Robert Ferrante, who is accused in his wife’s cyanide poisoning death.
Testimony in the trial of a University of Pittsburgh researcher accused of poisoning his wife with cyanide last year continued Thursday.
The trial of a University of Pittsburgh researcher accused of poisoning his wife with cyanide last year continued Wednesday.
The trial of a University of Pittsburgh researcher accused of poisoning his wife with cyanide is continuing today with testimony from the victim’s mother.
The trial of a Pitt researcher accused of killing his wife with cyanide resumed Monday morning.
Day two of the trial of a Pitt researcher accused of killing his wife with cyanide gets underway Friday.
Lawyers were expected to present opening statements in trial of a University of Pittsburgh medical researcher charged with killing his neurologist wife with cyanide – but when that happens will be determined by a last-minute problem with two alternate jurors.
The Sports Medicine Concussion Program at the University of Pittsburgh Medical Center has teamed with NASCAR driver Dale Earnhardt Jr. and catcher David Ross to raise awareness on concussion treatments.
As the nation grapples with Ebola, Sen. Bob Casey teamed up with doctors and specialists from UPMC Presbyterian Hospital Friday morning to discuss how prepared we are.
Officials say they’ve figured out how several patients at UPMC Presbyterian Hospital came down with a superbug.
The death of Thomas Eric Duncan, from the Ebola virus he contracted in West Africa, has now led to the first transmitted case of Ebola in the United States, in a nurse who cared for Duncan at Texas Health Presbyterian Hospital in Dallas.
The mistakes surrounding the United States’ first Ebola case has been well documented.
There is a lot of hype and speculation surrounding the Enterovirus D68, so the KDKA Afternoon News looks to help set the record straight.
Predicting how prostate cancer will progress has been much like flipping a coin. But a local discovery could change that.